Gene expression profile in the heart of spontaneous dwarf rat: In vivo effects of growth hormone

Biochemical and Biophysical Research Communications

Volumn 341, Issue 1, 2006, Pages 88-93

  Yoshioka, Shiro ^a   Takahashi, Yutaka ^a   Okimura, Yasuhiko ^b   Takahashi, Kentaro ^a   Iguchi, Genzo ^a   Iida, Keiji ^a   Kaji, Hidesuke ^c   Chihara, Kazuo ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c Department of Physiology and Biochemistry   (Japan)

Author keywords

Expression profile; Growth hormone; Heart; Microarray analysis; Spontaneous dwarf rat

Indexed keywords

ALDOSTERONE RECEPTOR; BETA ACTIN; COFILIN; GROWTH HORMONE; GUANYLATE CYCLASE; LAMIN A; LONG CHAIN FATTY ACID COENZYME A LIGASE; MESSENGER RNA; MYOSIN; THYMOSIN BETA4; TROPONIN T;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DOWN REGULATION; DWARFISM; GENE EXPRESSION; IN VIVO STUDY; MALE; MICROARRAY ANALYSIS; NONHUMAN; PRIORITY JOURNAL; RAT; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION;

ANIMALS; DWARFISM; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GROWTH HORMONE; HEART; MYOCARDIUM; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEOME; RATS;

ANIMALIA;

EID: 30944450161     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2005.12.157     Document Type: Article

References (37)

1. B.A. Bengtsson, S. Eden, I. Ernest, A. Oden, and B. Sjogren Epidemiology and long-term survival in acromegaly. A study of 166 cases diagnosed between 1955 and 1984 Acta Med. Scand. 223 1988 327 335
2. P. Chanson, J. Timsit, C. Masquet, A. Warnet, P.J. Guillausseau, P. Birman, A.G. Harris, and J. Lubetzki Cardiovascular effects of the somatostatin analog octreotide in acromegaly Ann. Intern. Med. 113 1990 921 925
3. A. Colao, G. Vitale, R. Pivonello, A. Ciccarelli, C. Di Somma, and G. Lombardi The heart: an end-organ of GH action Eur. J. Endocrinol. 151 Suppl. 1 2004 S93 S101
4. W.L. McGuffin Jr., B.M. Sherman, F. Roth, P. Gorden, C.R. Kahn, W.C. Roberts, and P.L. Frommer Acromegaly and cardiovascular disorders. A prospective study Ann. Intern. Med. 81 1974 11 18
5. M. Nishiki, Y. Murakami, M. Sohmiya, K. Koshimura, K. Inoue, Y. Goto, N. Nakamura, and Y. Kato Histopathological improvement of acromegalic cardiomyopathy by intermittent subcutaneous infusion of octreotide Endocr. J. 44 1997 655 660
6. T. Rosen, and B.A. Bengtsson Premature mortality due to cardiovascular disease in hypopituitarism Lancet 336 1990 285 288
7. B.A. Bengtsson, and G. Johannsson Effect of growth-hormone therapy on early atherosclerotic changes in GH-deficient adults Lancet 353 1999 1898 1899
8. S. Longobardi, A. Cuocolo, B. Merola, F. Di Rella, A. Colao, E. Nicolai, S. Cardei, M. Salvatore, and G. Lombardi Left ventricular function in young adults with childhood and adulthood onset growth hormone deficiency Clin. Endocrinol. (Oxf.) 48 1998 137 143
9. A. Frustaci, G.A. Perrone, N. Gentiloni, and M.A. Russo Reversible dilated cardiomyopathy due to growth hormone deficiency Am. J. Clin. Pathol. 97 1992 503 511
10. A. Colao, C. Di Somma, A. Cuocolo, L. Spinelli, W. Acampa, S. Spiezia, F. Rota, M.C. Savanelli, and G. Lombardi Does a gender-related effect of growth hormone (GH) replacement exist on cardiovascular risk factors, cardiac morphology, and performance and atherosclerosis? Results of a two-year open, prospective study in young adult men and women with severe GH deficiency J. Clin. Endocrinol. Metab. 90 2005 5146 5155
11. J. Isgaard, V. Kujacic, E. Jennische, A. Holmang, X.Y. Sun, T. Hedner, A. Hjalmarson, and B.A. Bengtsson Growth hormone improves cardiac function in rats with experimental myocardial infarction Eur. J. Clin. Invest. 27 1997 517 525
12. H. bJin, R. Yang, N. Gillett, R.G. Clark, A. Ko, and N.F. Paoni Beneficial effects of growth hormone and insulin-like growth factor-1 in experimental heart failure in rats treated with chronic ACE inhibition J. Cardiovasc. Pharmacol. 26 1995 420 425
13. R. Yang, S. Bunting, N. Gillett, R. Clark, and H. Jin Growth hormone improves cardiac performance in experimental heart failure Circulation 92 1995 262 267
14. M. Hongo, T. Ryoke, J. Schoenfeld, J. Hunter, N. Dalton, R. Clark, D. Lowe, K. Chien, and J. Ross Jr Effects of growth hormone on cardiac dysfunction and gene expression in genetic murine dilated cardiomyopathy Basic Res. Cardiol. 95 2000 431 441
15. S. Fazio, D. Sabatini, B. Capaldo, C. Vigorito, A. Giordano, R. Guida, F. Pardo, B. Biondi, and L. Sacca A preliminary study of growth hormone in the treatment of dilated cardiomyopathy N. Engl. J. Med. 334 1996 809 814
16. S. Genth-Zotz, R. Zotz, S. Geil, T. Voigtlander, J. Meyer, and H. Darius Recombinant growth hormone therapy in patients with ischemic cardiomyopathy: effects on hemodynamics, left ventricular function, and cardiopulmonary exercise capacity Circulation 99 1999 18 21
17. W.V. Houck, L.C. Pan, S.B. Kribbs, M.J. Clair, G.M. McDaniel, R.S. Krombach, W.M. Merritt, C. Pirie, J.P. Iannini, R. Mukherjee, and F.G. Spinale Effects of growth hormone supplementation on left ventricular morphology and myocyte function with the development of congestive heart failure Circulation 100 1999 2003 2009
18. R.C. Cuneo, P. Wilmshurst, C. Lowy, G. McGauley, and P.H. Sonksen Cardiac failure responding to growth hormone Lancet 1 1989 838 839
19. T. Takeuchi, H. Suzuki, S. Sakurai, H. Nogami, S. Okuma, and H. Ishikawa Molecular mechanism of growth hormone (GH) deficiency in the spontaneous dwarf rat: detection of abnormal splicing of GH messenger ribonucleic acid by the polymerase chain reaction Endocrinology 126 1990 31 38
20. F. Mantero, G. Opocher, D. Armanini, G. Paviotti, M. Boscaro, and M. Muggeo Plasma renin activity and urinary aldosterone in acromegaly J. Endocrinol. Invest. 2 1979 13 18
21. R.C. Cuneo, F. Salomon, P. Wilmshurst, C. Byrne, C.M. Wiles, R. Hesp, and P.H. Sonksen Cardiovascular effects of growth hormone treatment in growth-hormone-deficient adults: stimulation of the renin-aldosterone system Clin. Sci. (Lond.) 81 1991 587 592
22. J. Moller, N. Moller, E. Frandsen, T. Wolthers, J.O. Jorgensen, and J.S. Christiansen Blockade of the renin-angiotensin-aldosterone system prevents growth hormone-induced fluid retention in humans Am. J. Physiol. 272 1997 E803 E808
23. G. Strauch, M.B. Vallotton, Y. Touitou, and H. Bricaire The renin-angiotensin-aldosterone system in normotensive and hypertensive patients with acromegaly N. Engl. J. Med. 287 1972 795 799
24. P. Tollet-Egnell, A. Flores-Morales, N. Stahlberg, R.L. Malek, N. Lee, and G. Norstedt Gene expression profile of the aging process in rat liver: normalizing effects of growth hormone replacement Mol. Endocrinol. 15 2001 308 318
25. U. Zabel, M. Weeger, M. La, and H.H. Schmidt Human soluble guanylate cyclase: functional expression and revised isoenzyme family Biochem. J. 335 1998 51 517
26. J.P. Stasch, E.M. Becker, C. Alonso-Alija, H. Apeler, K. Dembowsky, A. Feurer, R. Gerzer, T. Minuth, E. Perzborn, U. Pleiss, H. Schroder, W. Schroeder, E. Stahl, W. Steinke, A. Straub, and M. Schramm NO-independent regulatory site on soluble guanylate cyclase Nature 410 2001 212 215
27. D.L. Vesely Human and rat growth hormones enhance guanylate cyclase activity Am. J. Physiol. 240 1981 E79 E82
28. R.H. Boger Nitric oxide and the mediation of the hemodynamic effects of growth hormone in humans J. Endocrinol. Invest. 22 1999 75 81
29. G. Bonne, M.R. Di Barletta, S. Varnous, H.M. Becane, E.H. Hammouda, L. Merlini, F. Muntoni, C.R. Greenberg, F. Gary, J.A. Urtizberea, D. Duboc, M. Fardeau, D. Toniolo, and K. Schwartz Mutations in the gene encoding lamin A/C cause autosomal dominant Emery-Dreifuss muscular dystrophy Nat. Genet. 21 1999 285 288
30. D. Fatkin, C. MacRae, T. Sasaki, M.R. Wolff, M. Porcu, M. Frenneaux, J. Atherton, H.J. Vidaillet Jr., S. Spudich, U. De Girolami, J.G. Seidman, C. Seidman, F. Muntoni, G. Muehle, W. Johnson, and B. McDonough Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease N. Engl. J. Med. 341 1999 1715 1724
31. M.C. Sanders, A.L. Goldstein, and Y.L. Wang Thymosin beta 4 (Fx peptide) is a potent regulator of actin polymerization in living cells Proc. Natl. Acad. Sci. USA 89 1992 4678 4682
32. F.X. Yu, S.C. Lin, M. Morrison-Bogorad, M.A. Atkinson, and H.L. Yin Thymosin beta 10 and thymosin beta 4 are both actin monomer sequestering proteins J. Biol. Chem. 268 1993 502 509
33. P. Lappalainen, and D.G. Drubin Cofilin promotes rapid actin filament turnover in vivo Nature 388 1997 78 82
34. E.M. De La Cruz, and T.D. Pollard Structural biology. Actin' up Science 293 2001 616 618
35. I. Bock-Marquette, A. Saxena, M.D. White, J.M. Dimaio, and D. Srivastava Thymosin beta4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair Nature 432 2004 466 472
36. A. Flores-Morales, N. Stahlberg, P. Tollet-Egnell, J. Lundeberg, R.L. Malek, J. Quackenbush, and N.H. Lee Norstedt Microarray analysis of the in vivo effects of hypophysectomy and growth hormone treatment on gene expression in the rat Endocrinology 142 2001 3163 3176
37. T.S. Tiong, and A.C. Herington Tissue distribution, characterization, and regulation of messenger ribonucleic acid for growth hormone receptor and serum binding protein in the rat Endocrinology 129 1991 1628 1634